Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

por Piette, François, Belmin, Joël, Vincent, Hélène, Schmidt, Nicolas, Pariel, Sylvie, Verny, Marc, Marquis, Caroline, Mely, Jean, Hugonot-Diener, Laurence, Kinet, Jean-Pierre, Dubreuil, Patrice, Moussy, Alain, Hermine, Olivier
Publicado 2011